<PAGE>

                                                                    Exhibit 31.2

I, Monica Tamborini, certify that:

         1. I have reviewed this annual report on Form 10-KSB of DNAPrint
genomics, Inc.

         2. Based on my knowledge, this annual report does not contain any
untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this
annual report;

         3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report.

         4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

                  (a) Designed such disclosure controls and procedures to ensure
                           that material information relating to the registrant,
                           including its consolidated subsidiaries, is made
                           known to us by others within those entities,
                           particularly during the period in which the periodic
                           reports are being prepared;

                  (b) Evaluated the effectiveness of the registrant's disclosure
                           controls and procedures as of a date within 90 days
                           prior to the filing of this annual report (the
                           "Evaluation Date"); and

                  (c) Presented in this annual report our conclusions about the
                           effectiveness of the disclosure controls and
                           procedures based on our evaluation as of the
                           Evaluation Date;

         5. The registrant's other certifying officers and I have disclosed,
based on our most recent evaluation, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons performing the
equivalent function):

                  (a) All significant deficiencies in the design or operation of
                           internal controls which could adversely affect the
                           registrant's ability to record, process, summarize
                           and report financial data and have identified for the
                           registrant's auditors any material weaknesses in
                           internal controls; and

                                       46
<PAGE>

                  (b) Any fraud, whether or not material, that involves
                           management or other employees who have a significant
                           role in the registrant's internal controls; and

         6. The registrant's other certifying officers and I have indicated in
this annual report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date:

/S/
-------------------------
Monica Tamborini
Chief Financial Officer

                                       47